Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lu AA21004 for Cognitive Dysfunction in Major Depressive Disorder
2011-005298-22Phase 2Completed
- Sponsor
- Takeda
- Start
- Apr 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of vortioxetine in major depressive disorder (MDD), confusion, sponsored by Takeda. Started Apr 2012; status: completed.
02
Drugs
vortioxetine
03
Conditions
major depressive disorder (MDD)confusion
Beyond the preview
Go deeper on 2011-005298-22.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-005298-22.